OMDA Earnings & Financial Statements
Omada Health
$18.22
-$0.08(-0.44%)
51
Overall
30
Value
60
Tech
65
Quality
Market Cap
$1.12B
Volume
1.64M
52W Range
$10.28 - $26.92
Target Price
$28.46
OMDA earnings and financial statements: Omada Health's income statement, balance sheet and cash flow statement, annual and quarterly.
OMDA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $260.21M | $169.80M | $122.78M | $89.19M |
| Cost of revenue | $89.27M | $66.92M | -$52.81M | -$46.39M |
| Operating income | -$11.97M | -$43.65M | $39.63M | $20.44M |
| EBITDA | -$682.0K | -$35.23M | $51.58M | $26.99M |
| Net income | -$12.78M | -$47.57M | $40.21M | $16.61M |
| EPS (diluted) | $-0.35 | $-6.11 | $-9.52 | $-3.57 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $305.41M | $150.89M | $175.08M | $221.80M |
| Total liabilities | $75.73M | $86.26M | $76.16M | $66.19M |
| Shareholders’ equity | $229.68M | -$384.40M | $98.92M | $155.60M |
| Cash and equivalents | $222.04M | $76.39M | $115.64M | $168.12M |
| Long-term debt | - | $29.77M | $29.79M | $30.16M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | $18.25M | -$34.18M | -$49.74M | -$68.98M |
| Capital expenditure | -$5.83M | - | - | - |
| Free cash flow | $12.42M | -$34.77M | -$50.15M | -$69.70M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OMDA | $18.22 | -0.4% | 1.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |